Crinetics Pharmaceuticals Inc (CRNX) stock has gained 80.36% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CRNX stock a score of 77 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 98. CRNX's rank also includes a short-term technical score of 89. CRNX has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on CRNX!